These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9337520)

  • 1. The value of immunohistochemical identification of neuroendocrine differentiation in non small cell lung carcinoma.
    Słodkowska J
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():23-7. PubMed ID: 9337520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of neuroendocrine differentiation in non-small cell lung cancer. The LCSG experience.
    Linnoila RI; Piantadosi S; Ruckdeschel JC
    Chest; 1994 Dec; 106(6 Suppl):367S-371S. PubMed ID: 7988266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchopulmonary carcinoid tumors--a significant diagnostic problem.
    Kedra P; Jeleń M; Szkudlarek-Gruszczyńska T; Leśkow E
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():146-61. PubMed ID: 9337533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroendocrine markers in lung cancer].
    Shen L
    Zhonghua Bing Li Xue Za Zhi; 1993 Aug; 22(4):201-3. PubMed ID: 8168175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine-specific protein (NSP)-reticulons as independent markers for non-small cell lung cancer with neuroendocrine differentiation. An in vitro histochemical study.
    Senden N; Linnoila I; Timmer E; van de Velde H; Roebroek A; Van de Ven W; Broers J; Ramaekers F
    Histochem Cell Biol; 1997 Aug; 108(2):155-65. PubMed ID: 9272435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of neuroendocrine differentiation in lung cancer cell lines featured by cytomorphology, markers, and their corresponding tumors.
    Linnoila RI
    J Cell Biochem Suppl; 1996; 24():92-106. PubMed ID: 8806093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine differentiation in non-small cell lung carcinomas.
    Baldi A; Groger AM; Esposito V; Di Marino MP; Ferrara N; Baldi F
    In Vivo; 2000; 14(1):109-14. PubMed ID: 10757067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer.
    Carles J; Rosell R; Ariza A; Pellicer I; Sanchez JJ; Fernandez-Vasalo G; Abad A; Barnadas A
    Lung Cancer; 1993 Dec; 10(3-4):209-19. PubMed ID: 7521264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsmall cell lung carcinoma with neuroendocrine differentiation--an entity of no clinical or prognostic significance.
    Ionescu DN; Treaba D; Gilks CB; Leung S; Renouf D; Laskin J; Wood-Baker R; Gown AM
    Am J Surg Pathol; 2007 Jan; 31(1):26-32. PubMed ID: 17197916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of neuroendocrine markers in non-small cell lung cancer: a comparative immunohistopathologic study.
    Kiriakogiani-Psaropoulou P; Malamou-Mitsi V; Martinopoulou U; Legaki S; Tamvakis N; Vrettou E; Fountzilas G; Skarlos D; Kosmidis P; Pavlidis N
    Lung Cancer; 1994 Dec; 11(5-6):353-64. PubMed ID: 7535640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of neuroendocrine feature about salivary adenoid cystic carcinoma.
    Sun C; Zhong M; Wang Z; Wang Y
    Chin J Dent Res; 1999 Dec; 2(3-4):65-7. PubMed ID: 10863420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal neuroendocrine differentiation in non-small cell carcinoma is not predicted by pre-operative routine investigation.
    Wallace WA
    Eur J Surg Oncol; 2002 Feb; 28(1):63-6. PubMed ID: 11869016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of frequent and independent p53 and bcl-2 expression in large-cell neuroendocrine carcinomas of the lung.
    Jiang SX; Kameya T; Shinada J; Yoshimura H
    Mod Pathol; 1999 Apr; 12(4):362-9. PubMed ID: 10229500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of so-called neuroendocrine lung tumors.
    Yesner R
    Exp Mol Pathol; 2001 Jun; 70(3):179-82. PubMed ID: 11417996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of neuroendocrine phenotype in non-small-cell lung cancer.
    Carnaghi C; Rimassa L; Garassino I; Santoro A
    Ann Oncol; 2001; 12 Suppl 2():S119-23. PubMed ID: 11762337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral granular cell tumours: a histological and immunocytochemical study.
    Williams HK; Williams DM
    J Oral Pathol Med; 1997 Apr; 26(4):164-9. PubMed ID: 9176790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer.
    Graziano SL; Mazid R; Newman N; Tatum A; Oler A; Mortimer JA; Gullo JJ; DiFino SM; Scalzo AJ
    J Clin Oncol; 1989 Oct; 7(10):1398-406. PubMed ID: 2550590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
    Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
    Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignancy prediction in endocrine pancreas neoplasias].
    Fernández-del Castillo C
    Rev Invest Clin; 2005; 57(3):481-7. PubMed ID: 16187709
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroendocrine differentiation in 32 cases of so-called sclerosing hemangioma of the lung: identified by immunohistochemical and ultrastructural study.
    Xu HM; Li WH; Hou N; Zhang SG; Li HF; Wang SQ; Yu ZY; Li ZJ; Zeng MY; Zhu GM
    Am J Surg Pathol; 1997 Sep; 21(9):1013-22. PubMed ID: 9298877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.